JAMA Network Home
Sign In
Research Letter

High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome

JAMA Dermatology 10.1001/jamadermatol.2025.3054

September 03, 2025 at 11:00 AM EDT

Read the full article

This cohort study examines high-throughput sequencing of the T-cell receptor to estimate relapse risk in patients with Sézary syndrome in clinical remission.

Corresponding Author: Alain H. Rook, MD, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104 (arook@pennmedicine.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2025.3054?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090325

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks